• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗心律失常的基因疗法:当前及新兴应用

Gene Therapy for the Treatment of Cardiac Arrhythmias: Current and Emerging Applications.

作者信息

Trivedi Amar, Arora Rishi

机构信息

Department of Cardiology, Northwestern Memorial Hospital, Chicago, IL, USA.

出版信息

J Innov Card Rhythm Manag. 2018 Dec 15;9(12):3440-3445. doi: 10.19102/icrm.2018.091204. eCollection 2018 Dec.

DOI:10.19102/icrm.2018.091204
PMID:32477792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252777/
Abstract

In this review, we examine the current state of gene therapy for the treatment of cardiac arrhythmias. We describe advances and challenges in successfully creating and incorporating gene vectors into the myocardium. After summarizing the current scientific research in gene transfer technology, we then focus on the most promising areas of gene therapy at this time, which is the treatment of atrial fibrillation and ventricular tachyarrhythmias. We also review the scientific literature to determine how gene therapy could potentially be used to treat patients with cardiac arrhythmias.

摘要

在本综述中,我们探讨了用于治疗心律失常的基因疗法的现状。我们描述了成功创建基因载体并将其整合到心肌中的进展与挑战。在总结了基因转移技术的当前科学研究之后,我们接着聚焦于目前基因疗法最具前景的领域,即心房颤动和室性快速心律失常的治疗。我们还查阅了科学文献,以确定基因疗法如何法如何可能用于治疗心律失常患者。

相似文献

1
Gene Therapy for the Treatment of Cardiac Arrhythmias: Current and Emerging Applications.用于治疗心律失常的基因疗法:当前及新兴应用
J Innov Card Rhythm Manag. 2018 Dec 15;9(12):3440-3445. doi: 10.19102/icrm.2018.091204. eCollection 2018 Dec.
2
Gene therapy for atrial fibrillation - How close to clinical implementation?心房颤动的基因治疗 - 离临床应用还有多远?
Int J Cardiol. 2019 Dec 1;296:177-183. doi: 10.1016/j.ijcard.2019.07.057. Epub 2019 Aug 7.
3
Arrhythmias in the intensive care patient.重症监护患者的心律失常
Curr Opin Crit Care. 2003 Oct;9(5):345-55. doi: 10.1097/00075198-200310000-00003.
4
Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.介入电生理学及其在心律失常治疗中的作用。
Ann Acad Med Singap. 1998 Mar;27(2):248-54.
5
Gene Therapy for Cardiac Arrhythmias.心律失常的基因治疗
Acta Cardiol Sin. 2013 May;29(3):226-34.
6
Ablation therapy for cardiac arrhythmias.心律失常的消融治疗。
Am J Cardiol. 1997 Oct 23;80(8A):56G-66G. doi: 10.1016/s0002-9149(97)00714-5.
7
Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.新型双腔植入式心脏复律除颤器系统的全球临床经验。
J Cardiovasc Electrophysiol. 2001 May;12(5):521-8. doi: 10.1046/j.1540-8167.2001.00521.x.
8
Catheter ablation for cardiac arrhythmias.心律失常的导管消融治疗。
Minerva Cardioangiol. 2002 Jun;50(3):189-207.
9
Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.双腔植入式心脏复律除颤器治疗室性心律失常患者时起搏治疗对房性快速性心律失常的疗效
Circulation. 2001 Aug 21;104(8):887-92. doi: 10.1161/hc3301.094739.
10
Gene therapy to treat cardiac arrhythmias.基因治疗心律失常。
Nat Rev Cardiol. 2015 Sep;12(9):531-46. doi: 10.1038/nrcardio.2015.61. Epub 2015 Apr 28.

引用本文的文献

1
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications.心律失常的基因治疗:机制、方式及治疗应用
Med Sci (Basel). 2025 Jul 30;13(3):102. doi: 10.3390/medsci13030102.

本文引用的文献

1
Genome editing in cardiovascular diseases.心血管疾病中的基因组编辑。
Nat Rev Cardiol. 2017 Jan;14(1):11-20. doi: 10.1038/nrcardio.2016.139. Epub 2016 Sep 9.
2
Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.左心房后壁中显性负性转化生长因子-β II型受体的组成性表达导致心房颤动基质的有益重塑。
Circ Res. 2016 Jun 24;119(1):69-82. doi: 10.1161/CIRCRESAHA.115.307878. Epub 2016 May 23.
3
Catecholaminergic polymorphic ventricular tachycardia: An exciting new era.儿茶酚胺能多形性室性心动过速:一个令人兴奋的新时代。
Ann Pediatr Cardiol. 2016 May-Aug;9(2):137-46. doi: 10.4103/0974-2069.180645.
4
The Use of Gene Therapy for Ablation of Atrial Fibrillation.基因疗法用于消除心房颤动
Arrhythm Electrophysiol Rev. 2014 Nov;3(3):139-44. doi: 10.15420/aer.2014.3.3.139. Epub 2014 Nov 29.
5
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.经皮基因治疗增强心脏病患者的钙水平(CUPID 2):一项随机、多中心、双盲、安慰剂对照、2b 期试验。
Lancet. 2016 Mar 19;387(10024):1178-86. doi: 10.1016/S0140-6736(16)00082-9. Epub 2016 Jan 21.
6
MicroRNA profiling of atrial fibrillation in canines: miR-206 modulates intrinsic cardiac autonomic nerve remodeling by regulating SOD1.犬类心房颤动的微小RNA分析:miR-206通过调节超氧化物歧化酶1来调控心脏固有自主神经重塑。
PLoS One. 2015 Mar 27;10(3):e0122674. doi: 10.1371/journal.pone.0122674. eCollection 2015.
7
Conceptual and technical aspects of transfection and gene delivery.转染与基因递送的概念及技术层面
Bioorg Med Chem Lett. 2015 Mar 15;25(6):1171-6. doi: 10.1016/j.bmcl.2015.01.018. Epub 2015 Jan 28.
8
Sonoporation: Gene transfer using ultrasound.声孔效应:利用超声波进行基因转移。
World J Methodol. 2013 Dec 26;3(4):39-44. doi: 10.5662/wjm.v3.i4.39.
9
A genome-wide association study to identify genomic modulators of rate control therapy in patients with atrial fibrillation.一项全基因组关联研究,旨在鉴定心房颤动患者心率控制治疗的基因组调节剂。
Am J Cardiol. 2014 Aug 15;114(4):593-600. doi: 10.1016/j.amjcard.2014.05.040. Epub 2014 Jun 6.
10
Percutaneous approaches for efficient cardiac gene delivery.经皮途径实现高效心脏基因转导。
J Cardiovasc Transl Res. 2013 Aug;6(4):649-59. doi: 10.1007/s12265-013-9479-7. Epub 2013 Jun 8.